| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-11 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-11 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-10 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.31 | 4e-10 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.29 | 3e-07 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-07 |